About Us

Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

A Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Social Media

Bluesky • Facebook • Instagram • LinkedIn • YouTube

Meet the Laser Focus World Team

Editorial

Sales

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology
My Watchlist
Indicators
Industrial Laser Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

5 Must-Read Analyst Questions From Sotera Health Company’s Q2 Earnings Call

By: StockStory

SHC Cover Image

Sotera Health’s second quarter performance was met with a significant positive market reaction, underpinned by strength in its Sterigenics and Nelson Labs segments. Management attributed the quarter’s outperformance to robust volume and pricing in sterilization services, as well as continued efficiency gains in laboratory testing. CEO Michael Petras pointed to "growing momentum across our core businesses," highlighting both increased customer demand and successful optimization initiatives within Nelson Labs. The company’s deliberate focus on operational improvements and capacity expansion were key themes discussed during the call.

Is now the time to buy SHC? Find out in our full research report (it’s free).

Sotera Health Company (SHC) Q2 CY2025 Highlights:

  • Revenue: $294.3 million vs analyst estimates of $275.6 million (6.4% year-on-year growth, 6.8% beat)
  • Adjusted EPS: $0.20 vs analyst estimates of $0.17 (15.9% beat)
  • Adjusted EBITDA: $150.7 million vs analyst estimates of $137.2 million (51.2% margin, 9.8% beat)
  • Management raised its full-year Adjusted EPS guidance to $0.78 at the midpoint, a 7.5% increase
  • Operating Margin: 30%, up from 27.8% in the same quarter last year
  • Organic Revenue rose 6.2% year on year vs analyst estimates of flat growth (612.7 basis point beat)
  • Market Capitalization: $4.48 billion

While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our Top 5 Analyst Questions From Sotera Health Company’s Q2 Earnings Call

  • Patrick Donnelly (Citi) asked if Sterigenics’ strong performance reflected any customer pull-forward due to tariff concerns. CEO Michael Petras said there was no material pull-in, attributing growth to consistent volume progression and capacity expansion.
  • Brett Fishbin (KeyBanc) questioned the drivers behind Nelson Labs’ margin improvement. Petras detailed that labor productivity and a favorable service mix, especially increased core lab testing, were key factors with no incremental optimization actions in the quarter.
  • Luke Sergott (Barclays) asked how much further margin expansion Nelson Labs could achieve. Petras responded that margins are now at the low to mid-30s percent range, consistent with management’s long-term expectations.
  • Jason Bednar (Piper Sandler) inquired about the impact of medtech supply chain shifts on Sterigenics. Petras indicated ongoing discussions with customers but no significant volume impact yet, noting the company’s strong U.S. capacity positioning.
  • Casey Woodring (JPMorgan) asked about the outlook for Nelson Labs in 2026 after a return to growth is expected in Q4. Petras declined to provide detailed 2026 guidance but emphasized a focus on core lab volume and ongoing regulatory compliance.

Catalysts in Upcoming Quarters

In the coming quarters, the StockStory team will be tracking (1) the pace of Sterigenics capacity additions and their impact on volume growth, (2) Nelson Labs’ ability to sustain margin improvements as core testing volumes recover and regulatory developments unfold, and (3) the progress of emissions control investments in response to evolving ethylene oxide regulations. We will also monitor how disciplined capital deployment and leverage reduction initiatives influence free cash flow generation.

Sotera Health Company currently trades at $15.50, up from $11.24 just before the earnings. In the wake of this quarter, is it a buy or sell? See for yourself in our full research report (it’s free).

The Best Stocks for High-Quality Investors

When Trump unveiled his aggressive tariff plan in April 2025, markets tanked as investors feared a full-blown trade war. But those who panicked and sold missed the subsequent rebound that’s already erased most losses.

Don’t let fear keep you from great opportunities and take a look at Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.

More News

View More
General Dynamics Hits New Highs: Why It Might Keep Climbing
Via MarketBeat
Tickers GD
Nike’s Turnaround: If the Shoe Fits, Buy It!
Via MarketBeat
Tickers NKE
NVIDIA Breaks Out to New Highs: What Comes Next?
Via MarketBeat
Topics Economy Stocks World Trade
Tickers CRWV META NVDA
Microsoft Stock Hits Stride in 2025—How Much More Can It Run?
Via MarketBeat
Topics Artificial Intelligence Retirement
Tickers MSFT
How Berkshire's OxyChem Buy Cements Its Long-Term Strength
Via MarketBeat
Tickers BRK BRK-A BRK-B OXY
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.